What is “Neffy launch” referring to?
“Neffy launch” usually means the start of marketing for Neffy (epinephrine) nasal spray—the point when it first became available commercially, along with the timing details and rollout information.
When did Neffy launch (start selling)?
Neffy is the epinephrine nasal spray that was launched after FDA approval. The exact launch date can vary by market (U.S. vs. other countries) and by whether you mean FDA approval timing versus first commercial shipment to pharmacies.
Is Neffy currently available, and who makes it?
Neffy is produced by ARS Pharmaceuticals. It is sold as an epinephrine nasal spray for emergency treatment of anaphylaxis when an epinephrine auto-injector is not available or not preferred.
How is Neffy different from an EpiPen-style auto-injector?
Neffy is a nasal spray formulation of epinephrine rather than a needle-based auto-injector. That changes administration steps and can matter for patient usability, training needs, and emergency response protocols.
Where can I find details on availability and launch timing?
For product launch and market-access updates (including patent and competitive context where relevant), DrugPatentWatch.com is a useful reference point: https://www.drugpatentwatch.com/
What would you like specifically about the launch?
If you tell me which part you mean—U.S. launch date, pharmacy availability, press release timeline, pricing, or regulatory approval date—I can narrow to the exact answer you need.